Pharmacokinetics of Cyclosporin in Nephrotic Syndrome
NCT01616446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2012-06-11
Summary
The purpose of this study is to evaluate whether there are differences in the pharmacokinetics of cyclosporine in remission nephrotic syndrome compared to relapsed disease in children.
Conditions
- Nephrotic Syndrome
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2009-08-31
- Completion
- 2010-02-28
Countries
- Brazil
Study Locations
More Related Trials
-
B Cells in Idiopathic Nephrotic Syndrome
NCT05712369 ·Status: COMPLETED ·Phase: NA
-
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
NCT00430105 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dupilumab Therapy in Nephrotic Syndrome in Children
NCT07091175 ·Status: RECRUITING ·Phase: PHASE2
-
Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
NCT00404482 ·Status: COMPLETED
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT01576367 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
NCT01861561 ·Status: TERMINATED ·Phase: PHASE4
-
Cyclosporine in Patients With Moderate COVID-19
NCT04412785 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy
NCT05782933 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001155 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
NCT07087314 ·Status: RECRUITING ·Phase: PHASE2
-
Registry of IgA Nephropathy in Chinese Children
NCT03015974 ·Status: RECRUITING
-
Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
NCT03170323 ·Status: UNKNOWN ·Phase: PHASE4
-
Rituximab in the First Episode of Paediatric Nephrotic Syndrome
NCT05850546 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
NCT05101447 ·Status: WITHDRAWN ·Phase: PHASE2
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
NCT00228020 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
NCT04817618 ·Status: RECRUITING ·Phase: PHASE3
-
Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis
NCT00801463 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
NCT01451710 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
NCT00991146 ·Status: COMPLETED ·Phase: PHASE3
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)
NCT05162066 ·Status: TERMINATED ·Phase: PHASE2